Screener
AbbVie ABBV EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by AbbVie in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: AbbVie’s 8-K, filed July 31, 2026. Open the filing →
- Filed
- Jul 31, 2026, 7:51 AM EDT
- Accession
- 0001551152-26-000023
FAQ
- What is AbbVie's EPS (diluted)?
- AbbVie (ABBV) reported EPS (diluted) of $2.03 in Q2 2026.
- How has AbbVie's EPS (diluted) changed year-over-year?
- AbbVie's EPS (diluted) increased by 290.4% year-over-year, from $0.52 to $2.03.
- What is the long-term trend for AbbVie's EPS (diluted)?
- Over 4 years (2021 to 2025), AbbVie's EPS (diluted) has grown at a -22.2% compound annual growth rate (CAGR), from $6.45 to $2.36.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about AbbVie's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude